| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |